Abstract
Background
A significant association between women’s reproductive traits and the risk of schizophrenia (SCZ) has been discovered, but the causalities remain unclear. We designed a two-sample univariate Mendelian randomization (MR) study using female-specific SNPs collected from a large-scale genome-wide association study as a genetic tool to explore the causal effect of female reproductive traits on the risk of SCZ, and conducted a multivariate MR study to re-validate the above findings.
Methods
From extensive genome-wide association studies (GWAS) of people with European ancestry (n = 176,881 to 418,758 individuals), summary-level data on five female reproductive variables were extracted. Summary-level information on SCZ was taken from a GWAS meta-analysis involving 320,404 people with European ancestry. The inverse variance weighting estimations for both univariable MR (UVMR) and multivariable MR (MVMR) were presented as the primary results. MR-Egger, weighted median, simple mode, and weighted mode regression methods for UVMR, and MVMR-Egger, MVMR-Lasso, and MVMR-median methods for MVMR were used for sensitivity analyses.
Results
The UVMR produced compelling proof for a connection between genetically predicted later age at first sexual intercourse (AFS) (OR, 0.632; 95% CI, 0.512–0.777; P < 0.01) and decreased SCZ risk. Pleiotropy analysis of the AFS-SCZ association confirmed the robustness of the MR results (P > 0.05). Consistent, substantial causal effects of AFS (OR, 0.592; 95%CI, 0.407–0.862; P < 0.01) on the risk of SCZ were demonstrated after adjusting for body mass index, years of schooling, and smoking initiation using MVMR.
Conclusions
Our findings provide convincing evidence that early AFS is a risk factor for SCZ. SCZ risk may be decreased by raising awareness of reproductive healthcare for women.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Over the past three decades, the number of people struggling with mental illness has risen rapidly, from 80.8 million to 125.3 million [1]. Mental illnesses, in particular, place a sizeable economic burden on families and society [2], and schizophrenia (SCZ) is considered the most serious of all. SCZ is a heterogeneous disorder that includes positive symptoms (e.g., delusions and hallucinations), negative symptoms (e.g., flat mood and lack of motivation), and cognitive symptoms (e.g., decreased executive functioning) [3]. Many people with this disorder do not fully recover, and those who enter periods of remission often experience shame and social isolation [4, 5]. Compared to male patients with SCZ, female patients have higher rates of insomnia and poorer performance on several dimensions of cognition including visuospatial/structural and language [5]. Aside from conventional risk factors for SCZ, emerging evidence has identified additional sex-specific risk factors for women related to female reproductive traits [6, 7].
Women’s reproductive traits, such as age at first birth (AFB), age at first sexual encounter (AFS), age at menarche (AAM), age at last live birth (ALB), and age at menopause (AMP), have a significant bearing on a population’s capacity for evolutionary adaptation and later-life health [8]. Numerous observational studies [9,10,11,12] have found that children with younger or older parents are more likely to have a variety of mental health problems than children of average-aged parents, with a particular emphasis on the risk of SCZ in children related to parental age. In addition, people with mental illness and their relatives may be more likely to engage in risky and impulsive behaviors that can lead to premature sexual intercourse or early pregnancy and childbirth in women [13]. Moreover, age at menopause and at menarche are frequently closely linked to mental health risks [14, 15]. In addition to epidemiological findings, the phenotypic association between female reproductive features and the risk of SCZ may have a genetic foundation [16,17,18,19]. Nonetheless, it is unclear whether these variations in female reproductive traits increase the likelihood of developing SCZ or whether they are all caused by other underlying evidence.
Concerning the rapid growth of genome-wide association studies (GWAS), Mendelian randomization (MR) analysis applying single nucleotide polymorphisms (SNPs) closely connected to phenotypes as instrumental variables (IVs), is becoming increasingly commonplace [20]. Considering SNPs are given at random during pregnancy and always predate illness manifestation, MR findings are less subject to confounding and reverse causation, which are key drawbacks of traditional observational research [21]. As a result, there is reason to suppose that the results of MR are stable and convincing to some extent. Guiyan Ni et.al [22] recently discussed the relationship between six psychiatric disorders and female reproductive traits using a two-sample MR method, and they found an evident causal association between attention-deficit/hyperactivity disorder and female reproductive traits (AFB, AFS, & AMP). With the massive update and public availability of the GWAS database on various clinical and subclinical aspects of psychiatric disorders, a new round of discussion on women’s health and psychiatric disorders has been initiated [23,24,25]. A causal association between female reproductive traits (AFB, AFS, &AAM) and major depression has recently been shown through a scientific design using MR methods [26]. Notably, it also provides new opportunities to explore the relationship between female reproductive traits and the risk of SCZ.
In this study, using just-available summary genetic association statistics from large-scale GWASs, we performed a two-sample MR study to explore the causal associations between women’s reproductive traits (AFB, AFS, AMP, ALB, & AAM) and the risk of SCZ. We utilized multivariable MR for evidence that women’s reproductive traits had a substantial causal influence on the risk of SCZ, independent of indicated modifiable risk factors. Our aim was to gain a comprehensive understanding of the impact of reproductive factors on SCZ and to re-evaluate the results from a genetic perspective.
Methods
Study design
A brief description of the two-sample Mendelian randomization (MR) designs is displayed in Fig. 1. To thoroughly investigate the connections between five women’s reproductive traits on the risk of SCZ, we conducted two-sample univariable MR (UVMR) and multivariable MR (MVMR). UVMR rests on three main assumptions: (1) The exposure has a substantial correlation with the genetic variation determined as the instrumental variable (Assumption 1); (2) The genetic variation in discussion is not linked to any confounding factors (Assumption 2); (3) Genetic variation influences outcome only through exposure, not via other pathways (Assumption 3) [27]. In comparison to the UVMR assumptions, the initial assumption of MVMR (Assumption 4) was the genetic variations related to one or more of the exposures, whereas the remaining assumptions were consistent with UVMR [28]. First, we chose genetic variations for each woman’s reproductive trait. Second, we used MVMR models to evaluate the direct influence of reproductive variables on the risk of SCZ while adjusting for the modifiable risk factors.
Data sources
The exposures in the present analysis included women’s reproductive features such as AFB, AFS, AAM, ALB, and AMP. The research outcome was the risk of SCZ. Summary-level data (effect estimates, standard errors, and P-values) for each trait were acquired from recent major European GWASs (Table 1).
Women’s reproductive traits
Mills et al. [29] carried out the largest GWAS meta-analysis which incorporated the data of 418,758 females for AFB, obtained from a total of 36 studies of European origin. AFB was measured as a continuous measurement for all women who had ever given birth. AFS genetic variations were also discovered in the largest GWAS, which included 214,547 females of European ancestry delivery from the UK Biobank [29].
AAM genetic variations were discovered by a GWAS meta-analysis which incorporated the data of 182,416 females of European ancestry, obtained from 57 studies in the ReproGen collaboration [30]. Each study incorporated autosomal SNP values that passed quality control procedures (including minor allele frequency > 1%) by meta-analysis and satisfied genome-wide significance levels in connection with age at menarche (P < 5 × 10−8).
The UK Biobank work presented summary-level data on age at last live birth and age at menopause (http://www.nealelab.is/uk-biobank). In the UK Biobank, the age at last live birth and at menopause are the age at which a woman gave birth to her last child and at which her menstruation ceased, respectively. The database includes the age at last live birth for 184,996 women and the age at menopause for 176,881 women. During the touch-screen phase, participants self-reported their age at last live birth and age at menopause. In addition, we utilized the second round of Neale Lab’s GWAS (https://gwas.mrcieu.ac.uk/datasets/). Genetic associations were adjusted for 20 genetic principal components as well as age [31].
Risk of schizophrenia
We utilized the Psychiatric Genomics Consortium’s (PGC) (https://pgc.unc.edu) GWAS for SCZ, which, at the study period, was the largest publicly accessible GWAS, involving 320,404 individuals of European ancestry (76,755 cases and 243,649 controls) [32]. Based on the UK Biobank data, the regression model was adjusted for gender, age, genotyping array, and the first eight major components of population structure. The inverse variance weighted method was applied to meta-analyze the summary statistics from the dataset to determine the relationships between SNPs and SCZ.
Selection of genetic instrumental variables
All SNPs for UVMR and MVMR are required to be firmly and independently predicted exposures from the published GWAS at genome-wide significance (P < 5 × 10−8) in order to comply with the MR assumptions (Fig. 1). We evaluated whether any of these SNPs were linked with covariates (body mass index, BMI; years of schooling, YS; physical activity, PA; smoking initiation, SI; alcoholic drinks per week, AD; coffee intake, CI) and outcome (risk of SCZ) at a P-value of 5 × 10−8 for UVMR by applying publically available GWAS summary data. In the UK Biobank, we utilized the second round of Neale Lab’s GWAS (https://gwas.mrcieu.ac.uk/datasets/). We collected SNPs corresponding to BMI, PA, and CI by meta-analyzing GWAS from approximately 461,460, 460,376, and 428,860 adult populations of European ancestry, respectively (http://www.nealelab.is/uk-biobank). A meta-analysis of GWASs on roughly 1.1 million European ancestors supplied by the prior meta-analysis of the Science Genetic Association Consortium (SSGAC) yielded genetic connections with YS [33]. In publications with sample sizes of up to 1.2 million participants, genetic correlations with other possible confounders (SI and AD) were also found. Table 1 provides extensive information on these investigations [34]. As with UVMR, we evaluated whether any of these SNPs were linked to confounders (BMI, YS, PA, SI, AD, and CI) and outcome (the risk of SCZ) in the MVMR. When the number of suitable instrumental variables is limited to 10 or fewer, the IV selection threshold should be relaxed to a p-value threshold of 1 × 10−6.
In addition, the F-statistic serves as a measure of the strength of instruments in predicting one exposure. It is applied to individual or summary-level data as well as to univariate or multivariate MR estimates. The mean F-statistic is calculated by summing two or more F-statistics associated with the exposure and subsequently computing their average. Hence, we calculated the mean F statistics of SNPs to evaluate their importance for UVMR [35]. The mean F-statistic was greater than 10, indicating that the SNPs for the UVMR exposures were valid. The conditional F statistic is a measurement instrument for predicting the strength of the effect of one exposure with the conditioned exposure on other exposures. The conditional F-statistic to measure the strength of SNPs for MVMR was not calculated when two samples were overlapped since the required pairwise covariances between SNP associations are only determinable using individual-level data [36].
Statistical analysis
SNPs that had been excluded in the outcome datasets were substituted with proxies in LDlink (https://ldlink.nci. nih.gov/) where linkage disequilibrium (LD) R2 was greater than 0.001 within 10 Mb. To identify the causal relationship between women’s reproductive characteristics and the risk of SCZ, we carried out UVMR on the data after extraction and harmonization. In the primary analysis, we determined a Wald ratio estimate for each genetic variation and used the inverse-variance weighted (IVW) approach to compile the estimates. A straightforward estimate is provided by the IVW with the multiplicative random effects method, which additionally takes into account any potential heterogeneity in the Wald ratio estimations from SNPs [37]. Therefore, random-effects IVW models are applied when there is heterogeneity; otherwise, the fixed-effect IVW model is used. We also conducted sensitivity analyses employing techniques with various assumptions for horizontal pleiotropy, such as MR-Egger regression, weighted median, simple mode, and weighted mode regression method, in order to evaluate the robustness of our findings. The MR-Egger intercept was examined to determine whether horizontal pleiotropy existed [38]. The Cochran Q test and I2 index were used to analyze the heterogeneity of causal impact estimates across every variation for each reproductive characteristic in women.
Previous studies have confirmed that BMI [39], CI [40], AD [40], SI [41], PA [42] and YS [43] are strongly associated with SCZ. Adjusted for variable risk factors, the MVMR analyses were performed to explore the influence of women’s reproductive factors on genetic susceptibility to developing SCZ. By executing MVMR-IVW and choosing random effects or fixed effects depending on heterogeneity as mentioned in UVMR, we extended the IVW MR method for MVMR. The MVMR-Egger, MVMR-Lasso, and MVMR-Median were employed for the sensitivity analyses. To account for both measurable and unmeasured pleiotropy, the MVMR-Egger intercept method was devised.
The results for the effect of AFS, ALB, AMP, AAM, and AFB on SCZ risk are presented as OR (95% CI). The Bonferroni method was used to correct for multiple testing. We considered associations with P-values below 0.01 (0.05/5) as strong evidence of associations. Results with P-values between 0.01 and 0.05 were regarded as suggestive associations. All analyses were two-sided and conducted using TwoSampleMR (version 0.5.7), Mendelian randomization (version 0.7.0), and MRPRESSO (version 1.0) packages in R software (version 4.2.3). Reporting of the study follows the STROBE-MR statement.
Results
UVMR analyses of women’s reproductive traits on the risk of schizophrenia
After LD clumping and deleting pleiotropic SNPs, we chose 62, 176, 66, five, and 107 SNPs as genetic instruments for AFB, AFS, AAM, ALB, and AMP, respectively (Supplementary Tables S1-S5). Women’s reproductive traits displayed mean F statistics ranging from 17.410 to 278.265 (Supplementary Table S6). The primary IVW approach revealed considerable evidence for an inversely causal link between AFS and the risk of SCZ (OR, 0.632; 95% CI, 0.512–0.777; P < 0.01; Fig. 2a and c). However, we discovered no evidence that AFB, AAM, ALB, or AMP had a direct influence on the risk of SCZ (all P > 0.05; Supplementary Table S7a). The results of the weighted median, MR Egger, simple and weighted models with the IVW method showed no directional pleiotropy, and the MR-Egger intercept test demonstrated no horizontal pleiotropy (Supplementary Table S7b).
MVMR analyses of women’s reproductive traits on the risk of schizophrenia
In the MVMR, substantial genome-wide genetic variations on BMI, YS, and SI are linked with each woman’s reproductive traits (Supplementary Table S8-S10). After adjusting for BMI, YS, and SI, substantial evidence also shows that genetic susceptibility to AFS has a direct inverse effect on the risk of SCZ (OR, 0.592; 95%CI, 0.407–0.862; P < 0.01) (Table 2). Furthermore, the MVMR identified no evidence of causal connections for AAM, AFB, ALB, and AMP (all P > 0.05; Table 2). The MVMR-Egger methods produced consistent findings (Table S7a), and the MVMR-median, MVMR-Lasso, and MVMR-Egger intercept tests revealed no horizontal pleiotropy (Supplementary Table S11).
Sensitivity analysis
Regarding the sensitivity analysis, MR-Egger, weighted median, simple mode, and weighted mode regression methods were employed to analyze the relationship between IV and outcome (Supplementary Table S7). In addition, forest plots for visualization of relevant results were used (Fig. 2a). Heterogeneity was assessed by the Q test, and heterogeneity (Q, 56.981–721.257; P < 0.05) was observed for all IVs. Due to the heterogeneity in the association analysis of AFS-SCZ (Q = 721.257), we applied random effects IVW. In addition, the causal association of AFS-SCZ was found to remain robust after removing each of the SNPs, which was also confirmed by leave-one-out plots (Fig. 2b). Potential polymorphic outlier SNPs were detected in the IVs-SCZ association using MR-PRESSO. Although outlier SNPs were present in the AFS-SCZ association, the causal association remained robust after the removal of the outlier SNPs (P < 0.01). Pleiotropy was not detected in the AFS-SCZ association pleiotropic test (P = 0.824). Funnel plots of the AFS-SCZ association were generally symmetrical, which was another indication of no horizontal pleiotropy (Fig. 2d).
Discussion
In the current study, we investigated the causal relationship between five female reproductive traits (AAM, ALB, AFB, AFS, and AMP) and the risk of SCZ. We utilized summary statistics from the largest GWAS conducted on these reproductive traits in a population of European ancestry and constructed robust instruments using exposure-related SNPs. Furthermore, we found a causal association between AFS-SCZ using UVMR analysis. The sensitivity analysis of the aforementioned results to other MR methods was robust and showed no evidence of horizontal pleiotropy. Notably, although the effect of AFS on the risk of SCZ was attenuated in the MVMR analysis, it was still statistically significant. Therefore, we conclude that premature female sexual activity increases the risk of SCZ in the largest sample size of the European population.
Adolescence and teenage years are known to prove to be a sensitive period for psychological and behavioral problems. This period of intense hormonal fluctuations is associated with a high incidence and worsening of potential mental illness [44]. From a gender perspective, women are more likely to have psychological complaints than men during that period [45]. Accordingly, first menstruation is going to be used as a valid factor for investigation of female puberty problems. In some studies, the early age of menarche has been found to be associated with mental health and behavioral problems [46]. Psychotic symptoms and suicidal and non-suicidal self-harming behaviors were more prevalent in students with early menarche than in those with on-time and delayed menarche [47]. However, the results of the current study did not find a causal association between age at menarche and the risk of SCZ. The findings of this study are consistent with some previous research [48, 49]. Therefore, the relationship between the two aforementioned factors remains controversial and needs to be further explored by further study. An equally controversial topic over the last several decades has been the relationship between menopause and SCZ [50, 51]. In contrast to men, women have a second peak in the onset of SCZ after the age of 40–45 years, which is associated with the onset of perimenopause in their lives [52]. As compelling evidence in support of the above, late-onset SCZ has been documented to be more frequent and more severe in women than in men [53, 54]. To explain the above phenomenon, the theory of menopausal risk has been proposed, which has been focused on the potential role of ovarian hormones (i.e., estrogen, progesterone) in women’s risk of psychiatric disorders in midlife [55]. In addition, there is growing evidence that (1) estrogen has a protective effect on neurons [56], (2) estrogen has been hypothesized to have an antidopaminergic effect [50], and (3) periods of the abrupt decrease in estrogen levels during a woman’s menstrual cycle and life cycle are associated with increased psychotic symptoms and vice versa [57]. Nevertheless, our research failed to find a causal link between AMP-SCZ by means of IVs. For the current scenario, we consider that menopausal status cannot be reliably predicted by age [58, 59]. Hence, age at menopause, as a proxy for its change, may be inadequate.
As society progresses and human civilization advances, we need to face a worldwide delay in reproduction [60]. There has also been extensive discussion about the relationship between parental age at childbirth and mental disorders [61,62,63]. It is well known that increasing maternal age at childbirth raises the risk of chromosomal segregation errors [64]. Moreover, there is growing recognition that maternal age at childbirth is associated with mental disorders [10, 11]. A relatively recent study by McGrath et al. (2014) [65] conducted a comprehensive analysis using household data extracted from the Danish Central Registry of Psychiatry and reported a U-shaped relationship between maternal age and the risk of SCZ. It was found that children of older mothers had a higher risk of the illness compared to younger mothers (25–29 years). In their second analysis, the risk of SCZ tended to be highly correlated with the age of the mother, controlling for the age of the father. Subsequently, the above findings were re-validated from the perspective of genetic association [17]. However, we failed to identify a causal association in females with SCZ regardless of the age of the first or last birth. A possible explanation may be the relatively small number of IVs selected for this study, and the existence of complex social, psychological, and biological effects between the age of the first or last birth and the risk of SCZ.
Information about people’s sexual and reproductive behaviors is rarely mentioned publicly, despite the fact that these behaviors play a prominent role in determining social and emotional well-being [66]. Sexual intercourse usually begins at puberty, with the first experiences for males and females beginning at approximately 16.8 and 17.2 years of age (https://kinseyinstitute.org/research/faq.php.). Unfortunately, accumulating evidence suggests that the onset of adolescent sexual activity has become earlier [67, 68]. Early sexual initiation is defined as the first sexual intercourse occurring before the age of 15 [69]. Early sexual intercourse is not only associated with having multiple sexual partners, inconsistent condom use, sexually transmitted infections, and unwanted pregnancies [70, 71], but also with mental health [72, 73]. A recent research study [74] selected data from the Seattle Social Development Project in Washington State (n = 808) and used linear logistic regression to analyze the strong association between early sexual initiation and poor mental health. The findings were consistent with a review that selected 28 studies [75]. Nevertheless, large cross-sectional studies involving 60,040 adolescents have expressed concern about the relationship between the two [76]. More importantly, one bidirectional two-sample Mendelian randomization study reconfirmed that, genetically, premature sexual behavior is a risk for major depression [77]. Similarly, the current study found a causal association between premature sexual intercourse and the risk of SCZ. In addition, given the strong associations between smoking [41], educational achievement [78] with SCZ, and female reproductive characteristics, the MVMR approach revalidated these findings, controlling for relevant factors. That is, early female sexual intercourse increases the risk of SCZ.
The potential mechanisms driving the causal link between premature sexual behavior and the susceptibility to SCZ may not follow a straightforward path. It is well known that adolescence is a sensitive time for physical development and hormonal fluctuations. As a mental health problem, behavioral difficulties occur in one in four adolescents [79] and can be categorized into externalizing and internalizing behavior problems. Adolescents with externalizing behavior problems are more likely to exhibit aggressive and risk-taking behaviors, while those with internalizing behavior problems exhibit withdrawal and depression [80]. Previous studies have reported that compared to others, adolescents with internalizing and externalizing symptoms are more likely to engage in early sexual activity [81, 82]. Early sexual activity leads to internal guilt, low self-esteem, bullying, and social stigma, which contribute to symptoms such as anxiety, depression and suicidal thoughts, and psychological distress [83]. In terms of psychosocial influences, parental and family factors have a significant impact on the age of sexual initiation of adolescents. Family factors associated with early sexual behavior include single-parent family structure, poor parent-adolescent relationships, low levels of parental supervision, and permissive parental attitudes toward sexual activity in previous studies [84, 85]. Another study analyzing school-age children in 50 countries found that parental supervision had a significant impact on reducing the odds of early sexual behavior among adolescents, especially for girls [86]. Based on bioecological theory, an analysis from the perspective of resilience shows that protective processes include adolescent academic performance, expectations, and school approval, in addition to close mother-child and father-child relationships, parental supervision, and family routines. Moreover, risk factors include criminal behavior and dangerous neighborhood environments, as well as the many factors mentioned above [87]. Perhaps active sexual health education for adolescents also needs to be accompanied by a multifaceted approach involving schools, families, and society, so as to promote adolescent mental health and reduce the risk of SCZ.
Early study has reported that the heritability of SCZ is as high as 80% [88]. Discussion has also proposed that SCZ is essentially a genetic disorder [89]. Therefore, it is necessary to explore the influence of female reproductive characteristics on SCZ from the perspective of genetic susceptibility. Although discussion [90] on this issue has been conducted, it has been mainly limited to gestational health. However, our study opted for five indicators that possess broader applicability and better represent women. Furthermore, this study used GWAS data related to a larger number of patients with SCZ, and modifiable risk factors were incorporated into the analysis in order to identify additional mechanisms of intervening in the development of the disease. Nevertheless, our research inevitably has some limitations. First, in our study, the GWAS data only corresponded to individuals of European ancestry. Therefore, the applicability of the study findings may be limited. Second, when we screened the IVs, numerous indicators of female reproductive characteristics, such as pregnancy loss, number of miscarriages, and number of stillbirths that did not meet the requirements, were not included. The subsequent generation of a new, large GWAS database may provide a more comprehensive assessment of the relationship between the two. Third, although we screened and controlled for the influence of some factors regarding the relationship between female reproductive characteristics and the risk of SCZ, reproductive behavior is complex, since it is influenced by different components including genetic, environmental, and socioeconomic factors, as well as their complex interactions. A limited number of factors, however, have been discussed in this study. Fourth, our study addressed the issue of female reproductive characteristics and genetic susceptibility to SCZ, while GWAS data for outcome variables and confounders failed to separate the male dataset. This increases the possibility of false-negative findings and caution should be exercised when generalizing the results of the study. Finally, racial differences may influence genetic susceptibility to SCZ. Given that our outcome variable involves multiple ethnic ancestries, our study has not yet ruled out the influence of this factor on the findings.
In summary, our findings provide convincing evidence that early AFS is a risk factor for SCZ. Promoting and educating adolescents about good sexual health may be an effective way to reduce the risk of SCZ.
Availability of data and materials
Data sources and methods for working with these data are detailed in the Materials and Methods and the Supplementary Tables; all data utilized in this investigation are freely available to the public. To facilitate communication, we have shared the R code for this study on GitHub (https://github.com/Forworks0410/a-flash-of-insight). Further details can be provided upon reasonable request by contacting the corresponding author.
Abbreviations
- AAM:
-
Age at menarche
- AD:
-
Alcoholic drinks per week
- AFB:
-
Age at first birth
- AFS:
-
Age at first sexual encounter
- ALB:
-
Age at last live birth
- AMP:
-
Age at menopause
- BMI:
-
Body mass index
- CI:
-
Coffee intake
- GWAS:
-
Genome-wide association studies
- IVs:
-
Instrumental variables
- IVW:
-
Inverse-variance weighted
- LD:
-
Linkage disequilibrium
- MR:
-
Mendelian randomization
- MVMR:
-
Multivariable Mendelian randomization
- PA:
-
Physical activity
- PGC:
-
Psychiatric Genomics Consortium
- SCZ:
-
Schizophrenia
- SNPs:
-
Single nucleotide polymorphisms
- SI:
-
Smoking initiation
- SSGAC:
-
Science Genetic Association Consortium
- UVMR:
-
Univariable Mendelian randomization
- YS:
-
Years of schooling
References
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9:137–50.
Picco L, Achilla E, Abdin E, Chong SA, Vaingankar JA, McCrone P, et al. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs. BMC Health Serv Res. 2016;16:173.
McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 2019;42:205–20.
Borrelli DF, Ottoni R, Maffei S, Marchesi C, Tonna M. The role of shame in schizophrenia delusion: the interplay between cognitive-perceptual and emotional traits. J Nerv Ment Dis. 2023;211:369–75.
Zhu R, Wang D, Tian Y, Du Y, Chen J, Zhou H, et al. Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia. Schizophr Res. 2022;240:143–9.
Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. AJP. 2006;163:927–9.
Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Devel Neurobio. 2012;72:1272–6.
Day FR, Helgason H, Chasman DI, Rose LM, Loh P-R, Scott RA, et al. Physical and neurobehavioral determinants of reproductive onset and success. Nat Genet. 2016;48:617–23.
D’Onofrio BM, Rickert ME, Frans E, Kuja-Halkola R, Almqvist C, Sjölander A, et al. Paternal age at childbearing and offspring psychiatric and academic morbidity. JAMA Psychiatry. 2014;71:432–8.
Grattan RE, Morton SE, Warhurst ES, Parker TR, Nicolson MP, Maha JLK, et al. Paternal and maternal ages have contrasting associations with self-reported schizophrenia liability. Schizophr Res. 2015;169:308–12.
Fountoulakis KN, Gonda X, Siamouli M, Panagiotidis P, Moutou K, Nimatoudis I, et al. Paternal and maternal age as risk factors for schizophrenia: a case–control study. Int J Psychiatry Clin Pract. 2018;22:170–6.
Lan K-C, Chiang H-J, Huang T-L, Chiou Y-J, Hsu T-Y, Ou Y-C, et al. Association between paternal age and risk of schizophrenia: a nationwide population–based study. J Assist Reprod Genet. 2021;38:85–93.
Ozcan NK, Boyacıoğlu NE, Enginkaya S, Dinç H, Bilgin H. Reproductive health in women with serious mental illnesses. J Clin Nurs. 2014;23:1283–91.
Platt JM, Colich NL, McLaughlin KA, Gary D, Keyes KM. Transdiagnostic psychiatric disorder risk associated with early age of menarche: a latent modeling approach. Compr Psychiatry. 2017;79:70–9.
Tiwari S, Prasad R, Wanjari MB, Sharma R. Understanding the impact of menopause on women with schizophrenia-Spectrum disorders: a comprehensive review. Cureus. 2023;15:e37979.
Barban N, Jansen R, de Vlaming R, Vaez A, Mandemakers JJ, Tropf FC, et al. Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nat Genet. 2016;48:1462–72.
Mehta D, Tropf FC, Gratten J, Bakshi A, Zhu Z, Bacanu S-A, et al. Evidence for genetic overlap between schizophrenia and age at first birth in women. JAMA Psychiatry. 2016;73:497–505.
Gratten J, Wray NR, Peyrot WJ, McGrath JJ, Visscher PM, Goddard ME. Risk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations. Nat Genet. 2016;48:718–24.
Ni G, Gratten J, Wray NR, Lee SH. Schizophrenia working Group of the Psychiatric Genomics Consortium. Age at first birth in women is genetically associated with increased risk of schizophrenia. Sci Rep. 2018;8:10168.
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.
Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.
Ni G, Amare AT, Zhou X, Mills N, Gratten J, Lee SH. The genetic relationship between female reproductive traits and six psychiatric disorders. Sci Rep. 2019;9:12041.
Demontis D, Walters GB, Athanasiadis G, Walters R, Therrien K, Nielsen TT, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023;55:198–208.
Giannakopoulou O, Lin K, Meng X, Su M-H, Kuo P-H, Peterson RE, et al. The genetic architecture of depression in individuals of east Asian ancestry: a genome-wide association study. JAMA Psychiatry. 2021;78:1258.
Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet. 2021;53:1276–82.
Wang Z, Lu J, Weng W, Fu J, Zhang J. Women’s reproductive traits and major depressive disorder: a two-sample Mendelian randomization study. J Affect Disord. 2023;326:139–46.
Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133–63.
Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181:251–60.
Mills MC, Tropf FC, Brazel DM, Van Zuydam N, Vaez A, eQTLGen Consortium, et al. Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour. Nat Hum Behav. 2021;5:1717–30.
Australian Ovarian Cancer Study. The GENICA network, kConFab, the LifeLines cohort study, the InterAct consortium, early growth genetics (EGG) consortium, et al. parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature. 2014;514:92–7.
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.
23andMe Research Team, COGENT (Cognitive Genomics Consortium), Social Science Genetic Association Consortium, Lee JJ, Wedow R, Okbay A, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112–21.
23andMe Research Team, HUNT All-In Psychiatry, Liu M, Jiang Y, Wedow R, Li Y, et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019;51:237–44.
Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10:486–96.
Sanderson E, Spiller W, Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med. 2021;40:5434–52.
Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36:1783–802.
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377–89.
Wootton RE, Lawn RB, Magnus MC, Treur JL, Corfield EC, Njølstad PR, et al. Associations between health behaviours, fertility and reproductive outcomes: triangulation of evidence in the Norwegian mother, father and child cohort study (MoBa). BMC Med. 2023;21:125.
Apostolakopoulou XA, Kontopoulou L, Karpetas GE, Marakis G, Vasara E, Katsaras IG, et al. Sugars, alcohol, and caffeine intake from drinks among outpatients with mental health disorders in Greece: a pilot study. Cureus. 2022; https://doi.org/10.7759/cureus.21563.
Sagud M, Mihaljevic Peles A, Pivac N. Smoking in schizophrenia: recent findings about an old problem. Current Opinion in Psychiatry. 2019;32:402–8.
Clinic for Mental Disorders “Dr Laza Lazarevic”, Belgrade, Serbia, Curcic D, Stojmenovic T, Sports Medicine Association of Serbia, Belgrade, Serbia, Djukic-Dejanovic S, Clinic for Mental Disorders “Dr Laza Lazarevic”, Belgrade, Serbia, et al. POSITIVE IMPACT OF PRESCRIBED PHYSICAL ACTIVITY ON SYMPTOMS OF SCHIZOPHRENIA: RANDOMIZED CLINICAL TRIAL. Psychiat Danub. 2017;29:459–65.
Luo Y, Pang L, Zhao Y, Guo C, Zhang L, Zheng X. Gender difference in the association between education and schizophrenia in Chinese adults. BMC Psychiatry. 2020;20:296.
Soares CN, Poitras JR, Prouty J. Hormone treatment for mood disorders in women. Expert Rev Neurother. 2002;2:25–34.
Bursalioglu FS, Aydin N, Yazici E, Yazici AB. The correlation between psychiatric disorders and Women’s lives. J Clin Diagn Res. 2013;7:695–9.
Lien L, Haavet OR, Dalgard F. Do mental health and behavioural problems of early menarche persist into late adolescence? A three year follow-up study among adolescent girls in Oslo, Norway. Soc Sci Med. 2010;71:529–33.
Deng F, Tao F-B, Wan Y-H, Hao J-H, Su P-Y, Cao Y-X. Early menarche and psychopathological symptoms in young Chinese women. J Women's Health (Larchmt). 2011;20:207–13.
Cohen RZ, Seeman MV, Gotowiec A, Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry. 1999;156:1059–64.
Hochman KM, Lewine RR. Age of menarche and schizophrenia onset in women. Schizophr Res. 2004;69:183–8.
Salokangas RK. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophr Res. 1995;16:7–16.
Becker D, Lomranz J, Pines A, Shmotkin D, Nitza E, BennAmitay G, et al. Psychological distress around menopause. Psychosomatics. 2001;42:252–7.
Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473–86.
Van Der Werf M, Hanssen M, Köhler S, Verkaaik M, Verhey FR, Investigators RISE, et al. Systematic review and collaborative recalculation of 133 693 incident cases of schizophrenia. Psychol Med. 2014;44:9–16.
Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treat. 2012;2012:1–9.
Riecher-Rössler A, Häfner H. Schizophrenia and oestrogens--is there an association? Eur Arch Psychiatry Clin Neurosci. 1993;242:323–8.
Toran-Allerand CD. The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci. 1996;18:36–48.
Seeman MV. The role of estrogen in schizophrenia. J Psychiatry Neurosci. 1996;21:123–7.
Chan S, Gomes A, Singh RS. Is menopause still evolving? Evidence from a longitudinal study of multiethnic populations and its relevance to women’s health. BMC Womens Health. 2020;20:74.
Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin N Am. 2011;38:425–40.
Sobotka T. Shifting parenthood to advanced reproductive ages: Trends, causes and consequences. 2010th edition. London: Springer. p. 129–54.
Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Advanced parental age and autism risk in children: a systematic review and meta-analysis. Acta Psychiatr Scand. 2017;135:29–41.
Zhang C, Yan L, Qiao J. Effect of advanced parental age on pregnancy outcome and offspring health. J Assist Reprod Genet. 2022;39:1969–86.
Hvide HK, Johnsen J, Salvanes KG. Parental age and birth defects: a sibling study. Eur J Epidemiol. 2021;36:849–60.
Hassold T, Hunt P. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew. Curr Opin Pediatr. 2009;21:703–8.
McGrath JJ, Petersen L, Agerbo E, Mors O, Mortensen PB, Pedersen CB. A comprehensive assessment of parental age and psychiatric disorders. JAMA Psychiatry. 2014;71:301–9.
Dickerson FB, Brown CH, Kreyenbuhl J, Goldberg RW, Fang LJ, Dixon LB. Sexual and reproductive behaviors among persons with mental illness. PS. 2004;55:1299–301.
Cornelius JR, Clark DB, Reynolds M, Kirisci L, Tarter R. Early age of first sexual intercourse and affiliation with deviant peers predict development of SUD: a prospective longitudinal study. Addict Behav. 2007;32:850–4.
Ferreira MMDSRDS, Torgal MCLDFPR. Life styles in adolescence: sexual behavior of Portuguese adolescents. Rev Esc Enferm USP. 2011;45:589–95.
Seff I, Steiner JJ, Stark L. Early sexual debut: a multi-country, sex-stratified analysis in sub-Saharan Africa. Glob Public Health. 2021;16:1046–56.
Kaestle CE. Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults. Am J Epidemiol. 2005;161:774–80.
Dunn MS, Yannessa J. Substance use as a predictor of engagement in early sexual behavior. Denver, CO: American Public Health Association National Convention; 2016.
Coker AL, Richter DL, Valois RF, McKeown RE, Garrison CZ, Vincent ML. Correlates and consequences of early initiation of sexual intercourse. J Sch Health. 1994;64:372–7.
Kugler KC, Vasilenko SA, Butera NM, Coffman DL. Long-term consequences of early sexual initiation on young adult health: a causal inference approach. J Early Adolesc. 2017;37:662–76.
Epstein M, Furlong M, Kosterman R, Bailey JA, King KM, Vasilenko SA, et al. Adolescent age of sexual initiation and subsequent adult health outcomes. Am J Public Health. 2018;108:822–8.
Lara LAS, Abdo CHN. Age at time of initial sexual intercourse and health of adolescent girls. J Pediatr Adolesc Gynecol. 2016;29:417–23.
Lee J. The impact of sexual initiation timing and sexual experience on depressive symptoms in south Korean adolescents: gender differences in a Nationwide cross-sectional study. J Pediatr Nurs. 2020;52:e15–20.
Lu Z, Sun Y, Liao Y, Kang Z, Feng X, Zhao G, et al. Identifying causal associations between early sexual intercourse or number of sexual partners and major depressive disorders: a bidirectional two-sample Mendelian randomization analysis. J Affect Disord. 2023;333:121–9.
Dickson H, Hedges EP, Ma SY, Cullen AE, MacCabe JH, Kempton MJ, et al. Academic achievement and schizophrenia: a systematic meta-analysis. Psychol Med. 2020;50:1949–65.
Egger HL, Angold A. Common emotional and behavioral disorders in preschool children: presentation, nosology, and epidemiology. J Child Psychol Psychiatry. 2006;47:313–37.
Epstein M, Bailey JA, Manhart LE, Hill KG, Hawkins JD. Sexual risk behavior in young adulthood: broadening the scope beyond early sexual initiation. J Sex Res. 2014;51:721–30.
Gambadauro P, Carli V, Hadlaczky G, Sarchiapone M, Apter A, Balazs J, et al. Correlates of sexual initiation among European adolescents. PLoS One. 2018;13:e0191451.
Kim HS. Sexual debut and mental health among south Korean adolescents. J Sex Res. 2016;53:313–20.
Pengpid S, Peltzer K. Prevalence and correlates of sexual risk behavior among school-going adolescents in four Caribbean countries. Behav Sci (Basel). 2020;10:166.
Babore A, Trumello C, Candelori C, Paciello M, Cerniglia L. Depressive Symptoms, Self-Esteem and Perceived Parent–Child Relationship in Early Adolescence. Front Psychol. 2016;7
Deptula DP, Henry DB, Schoeny ME. How can parents make a difference? Longitudinal associations with adolescent sexual behavior. J Fam Psychol. 2010;24:731–9.
Kushal SA, Amin YM, Reza S, Hossain FB, Shawon MSR. Regional and sex differences in the prevalence and correlates of early sexual initiation among adolescents aged 12–15 years in 50 countries. J Adolesc Health. 2022;70:607–16.
Lohman BJ, Billings A. Protective and risk factors associated with adolescent boys’ early sexual debut and risky sexual behaviors. J Youth Adolescence. 2008;37:723–35.
Hosak L. New findings in the genetics of schizophrenia. World J Psychiatry. 2013;3:57–61.
Hammond J, Lipsedge M. Assessing parenting capacity in psychiatric mother and baby units: a case report and review of literature. Psychiatr Danub. 2015;27(Suppl 1):S71–83.
Lawn RB, Sallis HM, Taylor AE, Wootton RE, Smith GD, Davies NM, et al. Schizophrenia risk and reproductive success: a Mendelian randomization study. R Soc Open Sci. 2019;6:181049.
Acknowledgments
We greatly appreciate all investigators for sharing these data.
Funding
This study was supported by Suzhou Key Technologies Program (SKY2021063); Suzhou clinical Medical Center for mood disorders (Szlcyxzx202109); Suzhou Clinical Key disciplines for Geriatric Psychiatry (SZXK202116); Shanghai Municipal Science and Technology Major Project (2018SHZDZX05); Suzhou Science and Technology Development Programme Youth Project (SKYD2023160), and National Mentorship Training Program for Young Health Professionals in Suzhou (Qngg2022027).
Author information
Authors and Affiliations
Contributions
Wenxi Sun: Conceptualization; Data curation; Formal analysis; Methodology; Software; Visualization; Funding acquisition; Roles/Writing original draft; Writing-review & editing. Xiaohui Wu: Conceptualization; Data curation; Formal analysis; Methodology; Roles/Writing-original draft; Editing. Haidong Yang & Shiting Yuan: Data curation; Formal analysis; Software; Validation; Editing. Jun Chen: Validation; Supervision; Editing. Yingru Fang & Xiaobin Zhang: Conceptualization; Methodology; Project administration; Supervision. Yiru Fang and Xiaobin Zhang contributed equally to this work and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
All studies included in cited genome-wide association studies were approved by a relevant review board. All participants provided informed consent.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1:
Supplementary materials associated with this article can be found online at Table S1-S11.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sun, W., Wu, X., Yang, H. et al. Identifying causal associations between women’s reproductive traits and risk of schizophrenia: a multivariate validated two-sample Mendelian randomization analysis. BMC Psychiatry 24, 161 (2024). https://doi.org/10.1186/s12888-024-05614-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12888-024-05614-5